Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-10

Clinical Trial Update: Multiprofen-CC™ to Reduce Pain After Total Knee Arthroplasty [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Multiprofen-CC for reducing postoperative pain after total knee arthroplasty; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Multiprofen-CC

Snippet

Sponsor: KAZM Pharmaceuticals Inc. | Conditions: Postsurgical Pain | Phase 3 | Status: RECRUITING